Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Aspirin Non-Responsiveness and Clopidogrel Endpoint Trial. (ASCET)
This study is ongoing, but not recruiting participants.
Study NCT00222261 Information provided by Ullevaal University Hospital
First Received: September 13, 2005 Last Updated: July 3, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Heart Disease
Angina Pectoris
Atherosclerosis
Additional conditions recognized in this trial
Coronary Artery Disease
Coronary Disease
Heart Diseases
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Chest Pain
Myocardial Ischemia
Pain
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
aspirin
clopidogrel
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Cardiovascular Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Platelet Aggregation Inhibitors
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Ullevaal University Hospital
The Norwegian Council for Cardiovascular Diseases.
The Scientific Board, Ullevål University Hospital.
Ada and Hagbart Waages Humanitarian and Charity Foundation
Alf and Aagot Helgesens Research Foundation.
Back to top of Main Content
